Overview
Lobbying Costs
None declared
None declared
Lobbyists (Full time equivalent)
2.25 Fte (3)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Eirhub
EU Transparency Register
468160048336-85 First registered on 08 Dec 2022
Goals / Remit
We advise private companies, investment funds, non-governmental organizations, and banks on strategic investment, business valuation, and search for acquisition targets within the Life Sciences sectors.
We consult Life Sciences-related organizations on topics related to Market Access regulations, processes, and stakeholders across Europe and Asia.
We aim to become a part of European community driving the positive change to public health issues, enhancement of cancer care delivery, patient access to care and development of healthcare systems in across the Europe.Main EU files targeted
- Regulation (EU) 2021/522 of the European Parliament and of the Council of 24 March 2021 on EU4Health programme for the period 2021-2027
- Communication of European Commission on Europe's Beating Cancer Plan
- European Commission implementation plan on EU Mission: Cancer
- EU Regulation 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR)
- Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
- Council Recommendation on strengthening prevention through early detection: A new EU approach on cancer screening replacing Council Recommendation 2003/878/EC
- Orphan Regulation (EC) No. 141/1200Address
Head Office
30th Zolotoustivska St, office 78
Kyiv 01135
UKRAINEEU Office
30th Zolotoustivska St, office 78
Kyiv 01135
UKRAINEWebsite
-
People
Total lobbyists declared
3
Employment time Lobbyists 75% 3 Lobbyists (Full time equivalent)
2.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
None declared
Lobbying costs for closed financial year
None declared
Major contributions in closed year
None declared
Clients for closed financial year
None declared
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
As we have not had previous experience in engaging in activities related to EU policies during 2022-2023, we are eager to embark on our activities in this way in 2024.
We intend to participate in consultations and negotiations with stakeholders under the Health Policy Platform, in particular, “Supporting Ukraine, neighbouring EU Member States and Moldova” initiatives and engage in funding and tenders activities in the field of health (in particular, cancer mission) announced by the European Commission (shorturl.at/qrtzE) and under EU4Health 2024 Annual Work Programme through European Health and Digital Executive Agency (HaDEA) (https://hadea.ec.europa.eu/calls-proposals_en) in the nearest future. Besides, we want to participate in the European Cancer Summit 2024 and other topic-related events.
- publication—White Paper "Cancer Care System in Ukraine" (https://eirhub.eu/report/info/cancer-care-system-in-ukraine-2.html)
- publication— Benchmarking report "Early and Expanded Access Pathways in Ukraine, Poland, and the Baltic States", 2023 (https://eirhub.eu/report/info/early-access-pathways-in-cee-15.html)Other activities
None declared
Meetings
Meetings
None declared